Table 1 Descriptive statistics for the overall sample.
Obese BMI (n = 61) | Non-obese BMI (n = 129) | p | |
---|---|---|---|
Age in years | 45.2 ± 16.7 | 41.0 ± 17.8 | 0.13 |
Female sex | 21 (34.4) | 40 (31.0) | 0.74 |
Diabetes | 10 (16.4) | 1 (0.8) | < 0.001* |
Hypertension | 20 (32.8) | 17 (13.2) | < 0.001* |
Hyperlipidemia | 7 (11.5) | 3 (2.3) | 0.01* |
Headache | 0 (0.0) | 1 (0.8) | 1.00 |
Pulmonary disease | 10 (16.4) | 14 (10.9) | 0.24 |
Renal disease | 6 (10.0) | 8 (6.2) | 0.37 |
Anxiety | 12 (19.7) | 17 (13.2) | 0.20 |
Depression | 11 (18.0) | 18 (14.0) | 0.41 |
Sleep disorder | 0 (0.0) | 3 (2.3) | 0.55 |
ASC (ng/mL) | 1.00 ± 0.7 | 0.87 ± 0.4 | 0.17 |
Caspase-1 (pg/mL) | 5185.35 ± 4114.3 | 6387.64 ± 5616.4 | 0.19 |
IL-18 (pg/mL) | 876.24 ± 477.1 | 626.5 ± 295.0 | 0.002* |
IL-1β (fg/mL) | 203.33 ± 978.4 | 79.25 ± 127.6 | 0.44 |
RPQ at 2 weeks | 23.0 ± 19.0 | 17.0 ± 14.2 | 0.03* |
RPQ at 6 months | 16.3 ± 17.7 | 13.4 ± 14.4 | 0.28 |
QOLIBRI-OS at 2 weeks | 47.0 ± 26.1 | 53.8 ± 25.6 | 0.14 |
QOLIBRI-OS at 6 months | 56.6 ± 28.2 | 63.1 ± 27.4 | 0.18 |
SF-12 physical at 2 weeks | 32.1 ± 11.0 | 34.9 ± 11.7 | 0.18 |
SF-12 physical at 6 months | 43.8 ± 11.7 | 46.8 ± 10.4 | 0.12 |